Extracorporeal ('ex vivo') connection of pig kidneys to humans. III. Studies of plasma complement activation and complement deposition in the kidney tissue

Xenotransplantation

Volumn 5, Issue 3, 1998, Pages 176-183

  Bengtsson, Anders ^a   Svalander, Christian T ^a   Mölne, Johan ^a   Rydberg, Lennart ^a   Breimer, Michael E ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Complement activation; Human xenoperfusion; Pig kidney

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3C; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5A;

ADULT; ANAPHYLAXIS; ARTICLE; CASE REPORT; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; CYTOKINE RELEASE; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; KIDNEY GRAFT REJECTION; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0031668230     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1998.tb00025.x     Document Type: Article

References (39)

1. BACH FH. Xenotransplantion: A view to the future. Transplantation Proc 1993; 25:25.
2. PLATT JL, VERCELLOTTI GM, DALMASSO AP, MATAS AJ, BOLMAN RM, NAJARIAN JS, BACH FH. Transplantation of discordant xenografts: A review of progress. Immunology Today 1990; 11:450.
3. WHITE D, WALLWORK J. Xenografting: Probability, possibility or pipe dream? Lancet 1993; 342:879.
4. DALMASSO AP. The complement system in xenotransplantation. Immunopharmacology 1992; 24:149.
5. SCHILLING A, LAND W, PRATSCHKE E, PIELSTICKER K, BRENDEL W. Dominant role of complement in the hyperacute xenograft rejection reaction. Surg Gyn Obstet 1976; 142:29.
6. LEVENTHAL JR, DALMASSO AP, CROMWELL JW, PLATT JL, MANIVEL CJ, BOLMAN III RM, MATAS AJ. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55:857.
7. PLATT JL, FISCHEL RJ, MATAS AJ, REIF SA, BOLMAN RM, BACH FH. Immunopathology of hyperacute rejection in a swine-to-primate model. Transplantation 1991; 52:214.
8. DALMASSO AP, VERCELLOTTI GM, FISCHEL RJ, BOLMAN RM, BACH FH, PLATT JL. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992; 140:1157.
9. JOHNSTON P, LIM S, WRIGHT L, WHITE D. Hyperacute xenograft rejections takes place in the complete absence of antibodies but requires the presence of functional complement. Transplant Proc 1991; 23:877.
10. FORTY J, WHITE DJG, WALLWORK J. Activation of the alternative pathway of complement in hyperacute xenograft of rabbit hearts by human blood. J Heart Lung Transplant 1993; 12:283.
11. ADACHI H, ROSENGARD BR, HUTCHINS GM, HALL TS, BAUNGARTENER WA, BORKON AM, REITZ BA. Effects of cyclosporine, aspirin, and cobra venom factor on discordant cardiac xenograft survival rats. Transplant Proc 1987; 19:1145.
12. SNYDER GB, BALLESTEROS E, ZARCO RM, LINN BS. Prolongation of renal xenografts by complement suppression. Surg Forum 1966; 17:478.
13. CHARTRAND C, O'REGAN S, ROBITAILLE P, PINTO-BLONDE M. Delayed rejection of cardiac xenografts in C6-deficient rabbits. Immunology 1979; 38:245.
14. PRUITT SK, BALDWIN WM, MARSH HC, LIN SS, YEH CG, BOLLINGER RR. The effect of soluble complement receptor type 1 on hyperacute xenograft rejeciton. Transplantation 1991; 52:868.
15. MORAN P, BEASLEY H, GORRELL A, MARTIN E, GRIBLING P, FUCHS H, GILLETT N, BURTON LE, CARAS IW. Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo. J Immunol 1992; 149:1736.
16. MIYAGAWA S, SHIKAKURA R, MATSUMIYA G, FUKUSHIMA N, NAKATA S, MATSUDA H, MATSUMOTO M, KITAMURA H, SEYA T. Prolonging discordant xenograft survival with anti-complement reagents K76COOH and FUT175. Transplantation 1993; 55:709.
17. REDING R, DAVIES S, WHITE DJG, WRIGHT LJ, MARBAIX E, ALEXANDRE GPJ, SQUIFFLET JP, CAINE RY. Effect on plasma exchange on guinea pig-to-rat heart xenograft. Transplant Proc 1989; 21:534.
18. MCCURRY KR, KOOYMAN DL, ALVARADO CG, COTTERELL AH, MARTIN MJ, LOGAN JS, PLATT JL. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Medicine 1995; 1:423.
19. MIYAGAWA S, IROSE H, SHIKAKURA R, NAKA Y, NAKATA S, KAWASHIMA Y, SEYA T, MATSUMOTO M, UENAKA A, KITAMURA H. The mechanism of discordant xenograft rejection. Transplantation 1988; 46:1157.
20. HOURCADE D, HOLERS VM, ATKINSON JP. The regulators of complement activation (RCA) gene cluster. Adv Immun 1989; 45:381.
21. ROLLINS S, ZHAO J, NINOMIYA H, SIMS P. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. J Immunol 1991; 146:2345.
22. CHARREAU B, CASSARD A, TESSON L, LE MAUFF B, NAVENOT J-M, BLANCHARD D, LUBLIN D, SOULILLOU J-P, ANEGON I. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/ or decay-accelerating factor. Transplantation 1994; 58:1222.
23. BALDWIN III WM, PRUITT SK, BRAUER RB, DAHA MR, SANFILIPPO F. Complement in organ transplantation. Contributions to inflammation, injury, and rejection. Transplantation 1995; 59:797.
24. LISZEWSKI MK, ATKINSON JP. The complement system. In Paul WE, ed. Fundamental Immunology. New York: Raven Press, Ltd., 1993, p. 917.
25. BREIMER M.E., BJÖRCK S., SVALANDER C.T., BENGTSSON A., RYDBERG L, LIE-KARLSEN K., ATTMAN P-O, AURELL M., SAMUELSSON B.E. Extracorporeal ("ex vivo") connection of pig kidneys to humans. I. Clinical data and studies of platelet destruction. Xenotransplantation 1996; 3:328.
26. RYDBERG L., BJÖRCK S., HALLBERG E., MAGNUSSON S., SUMITRAN S., SAMUELSSON B.E., STROKAN V., SVALANDER C.T., BREIMER M.E. Extra corporeal ("ex vivo") connection of pig kidneys to humans. II. The anti-pig antibody response. Xenotransplantation 1996; 3:340.
27. SCHMEKEL B, SVALANDER C, BUCHT H, WESTBERG NG. Mesangial IgA glomerulonephritis in adults. Acta Med Scand 1981; 210:363.
28. RÖNHOLM E, TOMASDOTTIR H, RUNEBORG J, BENGTSSON A, BENGTSON J-P, STENQUIST O, FRIMAN S. Complement system activation during orthotopic liver transplantation in man: Indications of peroperative complement system activation in the gut. Transplantation 1994; 57:1594.
29. SAATTVEDT K, LLNDBERG H, GEIRAN OR ET AL. Complement activation and release of tumour necrosis factor alpha, interleukin-2, interleukin-6 and soluble tumour necrosis factor and interleukin-2 receptors during and after cardiopulmonary bypass in children. Scand J Clin Invest 1995; 55:79.
30. GILLINOV AM, DEVALERIA PA, WINKELSTEIN JA ET AL. Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass. Ann Thorac Surg 1993; 55:619.
31. ZHAO Z, TERMIGNON J-L, CARDOSO J ET AL. Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. Transplantation 1994; 57:245.
32. SCHAAPHERDER AFM, GOOSZEN HG, TE BULTE M-TJW, DAHA MR. Human complement activation via the alternative pathway on porcine endothelium initiated by IgA antibodies. Transplantation 1995; 60:287.
33. COOPER DKC, HUMAN PA, LEXER G ET AL. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant 1988; 7:238.
34. KROSHUS TJ, BOLMAN III RM, DALMASSO AP. Selective IgM depletion prolongs organ survival in an ex vivo model of pig-to-human xenotransplantation. Transplantation 1996; 62:5.
35. WELSH KI, TAUBE DH, THICK M, PALMER A, STEVENS N, BINNS RM. Xenografts: Future prospects for clinical transplantation. Immunol Lett 1991; 29:167.
36. ROSENGARD AM, CARY NRB, LANGFORD GA, TUCKER AW, WALLWORK J, WHITE DJG. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs: A potential approach for preventing rejection. Transplantation 1995; 59:1325.
37. KROSHUS TJ, BOLMAN III RM, DALMASSO AP ET AL. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Transplantion 1996; 61:1513.
38. CHAPMAN LE, FOLKS TM, SALOMON DR, PATTERSON AP, EGGERMAN TE, NOGUCHI PD. Xenotransplantion and xenogeneic infections. N Engl J Med 1995; 333:1498.
39. MURPHY FA. The public health risk of animal organ and tissue transplantation into humans. Science 1996; 273:746.